Pharmacological closure of symptomatic PDA in premature infants using indomethacin

M. Y. Ho, F. Y. Huang, H. A. Kao

研究成果: 雜誌貢獻文章同行評審

1 引文 斯高帕斯(Scopus)

摘要

When left to right shunting through the ductus arteriosus is of a degree contributing to the cardiopulmonary problems in a premature infant, the condition is clinically termed symptomatic PDA. It is also generally agreed that symptomatic PDA if left untreated is a significant cause of increased morbidity and mortality. Studies have also concluded that all infants with symptomatic PDA who are prematurely born and/or ventilator dependent should be considered candidates for ductal closure by either pharmacological or surgical mean. Over a period of approximately 2 1/2 years, 22 premature infants with symptomatic PDA have been treated here with powder form indomethacin. The one course success rate was 68%. Thereafter, in another 2 1/2 years, 33 cases were selected for whom a liquid form was used instead. The success rate was 70%. Indomethacin is better given by an intravenous route. However, if the intravenous form is not available, using the liquid form by mouth or via the naso-gastric tube is a good substitute.

原文英語
頁(從 - 到)88-94
頁數7
期刊Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui
32
發行號2
出版狀態已發佈 - 一月 1 1991
對外發佈

ASJC Scopus subject areas

  • 兒科、圍產兒和兒童健康

指紋

深入研究「Pharmacological closure of symptomatic PDA in premature infants using indomethacin」主題。共同形成了獨特的指紋。

引用此